NasdaqCM - Delayed Quote USD
Tonix Pharmaceuticals Holding Corp. (TNXP)
23.10
+1.02
+(4.62%)
At close: May 15 at 4:00:00 PM EDT
26.32
+3.22
+(13.94%)
Pre-Market: 6:20:48 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | 1 |
| Avg. Estimate | 0 | 0 | 0 | -4.67 |
| Low Estimate | 0 | 0 | 0 | -4.67 |
| High Estimate | 0 | 0 | 0 | -4.67 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | 2.6M | 2.7M | 10.6M | 98.7M |
| Low Estimate | 2.6M | 2.7M | 10.6M | 31.3M |
| High Estimate | 2.6M | 2.7M | 10.6M | 166.1M |
| Year Ago Sales | 2.21M | 2.82M | 10.09M | 10.6M |
| Sales Growth (year/est) | 17.75% | -4.32% | 5.01% | 831.13% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -720 | -736 | -- | -3.09 |
| EPS Actual | -464.22 | -25.56 | -10.18 | -2.64 |
| Difference | 255.78 | 710.44 | -- | 0.45 |
| Surprise % | 35.53% | 96.53% | -- | 14.50% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | -4.67 |
| 7 Days Ago | 0 | 0 | 0 | -4.67 |
| 30 Days Ago | 0 | 0 | 0 | -4.67 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TNXP | -- | -- | -- | -- |
| S&P 500 | 13.17% | 2.85% | 7.92% | 13.78% |
Upgrades & Downgrades
| Reiterates | Noble Capital Markets: Outperform to Outperform | 3/20/2025 |
| Maintains | Alliance Global Partners: Buy to Buy | 7/22/2024 |
| Initiated | Dawson James: Buy | 2/28/2024 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/1/2023 |
| Maintains | Alliance Global Partners: Buy to Buy | 6/2/2023 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/31/2021 |
Related Tickers
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
CNSP CNS Pharmaceuticals, Inc.
1.2600
+9.57%
NCNA NuCana plc
0.0534
+54.34%
HCWB HCW Biologics Inc.
8.20
-6.92%
PLRZ Polyrizon Ltd.
0.0089
-29.37%
IOVA Iovance Biotherapeutics, Inc.
1.7600
+3.23%
CTMX CytomX Therapeutics, Inc.
2.0000
-15.97%
XLO Xilio Therapeutics, Inc.
0.8000
-5.88%
OCGN Ocugen, Inc.
0.7093
+2.12%
SEPN Septerna, Inc.
10.12
-0.39%